Light-Activated Nano-Robots Can Help Targeted Breast Cancer Therapy

Key Highlights:

• Researchers from INST, Mohali and BARC, Mumbai developed light-activated nanobots for targeted breast cancer therapy.
• The nanobots are based on Upconversion Nanoparticle (UCNP) technology, activated by Near-Infrared (NIR) light.
• They exhibit directional movement (phototaxis) and are functionalized with folic acid for selective targeting of cancer cells.
• The therapy combines photothermal heating and photodynamic therapy to destroy cancer cells.
• Therapeutic efficacy has been demonstrated in both cellular models and breast tumor-bearing mice.

Detailed Insights:

• Conventional chemotherapy often causes severe side effects and damages healthy tissues due to non-specific drug distribution.
• Current nanomedicines primarily rely on passive tumor accumulation, leading to limited tissue penetration and poor spatial control.
• The developed nanobots convert NIR light into heat and generate Reactive Oxygen Species (ROS), enabling localized therapeutic action.
• Folic acid on the nanobot surface allows specific recognition and targeting of breast cancer cells overexpressing folate receptors.
• This approach offers precise, externally controlled, and minimally invasive treatment, enhancing tumor inhibition compared to individual therapies.

Scientific/Technical Concepts Involved:

• Upconversion Nanoparticle (UCNP): Nanomaterials capable of converting low-energy NIR light into higher-energy visible or ultraviolet light.
• Near-Infrared (NIR) light: A type of electromagnetic radiation with longer wavelengths than visible light, allowing deeper tissue penetration.
• Phototaxis: The directional movement of an organism or cell in response to a light stimulus.
• Photodynamic Therapy (PDT): A treatment using a photosensitizer and light to produce ROS that kill cancer cells.
• Photothermal Therapy (PTT): A treatment using light-absorbing materials to generate heat, destroying cancer cells.